期刊文献+

人参皂苷Rg1改善小鼠肢体缺血后血管新生 被引量:4

Effects of ginsenoside-Rg1 on ischemia-induced angiogenesis in the mouse hindlimb
下载PDF
导出
摘要 目的:探讨人参皂苷Rg1是否具有促进小鼠缺血后肢血管新生的作用。方法:C57BL/6J小鼠随机分为两组:对照组(n=10)腹腔注射生理盐水0.1 mL,人参皂苷Rg1治疗组(n=10)腹腔注射Rg1(10 mg·kg^(-1))。每天1次,共2周。所有小鼠均结扎右后肢股动脉制作后肢缺血模型,手术后2周用多普勒血流成像评估双下肢血流,免疫荧光检测缺血肢体毛细血管密度,TUNEL法检测凋亡细胞,采用比色法检测缺血组织中一氧化氮浓度。结果:人参皂苷Rg1治疗能够改善小鼠缺血肢体的血流,且能明显地促进血管新生,提高缺血组织一氧化氮分泌,抑制缺血组织细胞的凋亡。结论:人参皂苷Rg1改善了小鼠缺血肢体血管新生及血流灌注。 Objective:To investigate whether Rgl could improve angiogenesis in ischemic hindlimb of mice in vivo.Methods:Mouse hindlimb ischemia model was established by ligating the right femoral artery.Animals were randomly divided into the following two groups(zi=10)for intraperitoneal treatment:Rgl(10 mg'k g-1?d_1)-treated group and saline as control group.The blood flow was assessed by laser Doppler imaging at 2 weeks after surgery.Ischemic muscle was harvested for immunofluorescence analysis for CD31,TUNEL assay for apoptotic activity and colorimetric determination of nitric oxide(NO)production at 2 weeks post-surgery.Results:Rgl promotes angiogenesis and blood reperfusion recovery.Moreover,Rgl treatment could also significantly improve secretion of NO,and inhibit cell apoptosis in ischemic tissues.Conclusion:Rgl promoted angiogenesis in ischemic hindlimb of mice and could be considered as a potential agent for therapeutic angiogenesis.
作者 王晓丽 金跃 刘鹭 张凯 杨乃全 WANG Xiao-li;JIN Yue;LIU Lu;ZHANG Kai;YANG Nai-quan
出处 《江苏大学学报(医学版)》 CAS 2018年第2期126-128,134,共4页 Journal of Jiangsu University:Medicine Edition
关键词 人参皂苷RGL 肢体缺血 血管新生 凋亡 ginsenoside-Rgl hindlimb ischemia angiogenesis apoptosis
  • 相关文献

参考文献2

二级参考文献23

  • 1Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res,2015,116 : 1509-1526. 被引量:1
  • 2Brownrigg JRW, Schaper NC, Hinchliffe RJ. Diagnosis and assessment of peripheral arterial disease in the diabetic foot. Diabet Med, 2015,32 : 738- 747. 被引量:1
  • 3Kramer CK, Rodrigues TC, Canani I.H, et al. Diabetic reti- nopathy predicts all cause mortality and cardiovascular events in both type 1 and 2 diahetes metanalysis of observational studies. Diabetes Care, 2011,34 : 1238-1244. 被引量:1
  • 4De Cosmo S,Rossi MC,Pellegrini F,et al. Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes. Nephrol Dial Transplant, 2014,29 : 657-662. 被引量:1
  • 5Sasso FC,Chiodini P, Carbonara O, et al. High cardiovascular risk in patients with type 2 diabetic nephropathy: the predic- tive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. Nephrol Dial Transplant, 2012,27:2269-2274. 被引量:1
  • 6Yun YW,Shin MH,Lee YH,et al. Arterial stiffness is associ ated with diabetic retinopathy in Korean type 2 diabetic pa- tients. J Prey Med Public Health,2011,44:260-266. 被引量:1
  • 7Gerstein HC,Ambrosius WT,Danis R,et al. Diabetic retinop- a thy,its progression,and incident cardiovascular events in the ACCORD trial. Diabetes Care, 2013,36 : 1266-1271. 被引量:1
  • 8Yu JH, Lee KU. Response: the prevalence of peripheral arte- rial disease in Korean patients with type 2 diabetes mellitus attending a university hospital. Diabetes Metab J, 2012, 36: 77-78. 被引量:1
  • 9Li X, Wang YZ, Yang XP, et al. Prevalence of and risk factors for abnormal ankle-brachial index in patients with type 2 dia betes. J Diabetes, 2012,4 : 140-146. 被引量:1
  • 10Chen YW,Wang YY,Zhao D,et al. High prevalence of lower extremity peripheral artery disease in type 2 diabetes patients with proliferative diabetic retinopathy. PLoS One, 2015,10: e0122022. 被引量:1

共引文献15

同被引文献49

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部